These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10421596)

  • 1. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery.
    VanderLugt JT; Mattioni T; Denker S; Torchiana D; Ahern T; Wakefield LK; Perry KT; Kowey PR
    Circulation; 1999 Jul; 100(4):369-75. PubMed ID: 10421596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
    Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
    Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study.
    Ellenbogen KA; Stambler BS; Wood MA; Sager PT; Wesley RC; Meissner MC; Zoble RG; Wakefield LK; Perry KT; Vanderlugt JT
    J Am Coll Cardiol; 1996 Jul; 28(1):130-6. PubMed ID: 8752805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation.
    Volgman AS; Carberry PA; Stambler B; Lewis WR; Dunn GH; Perry KT; Vanderlugt JT; Kowey PR
    J Am Coll Cardiol; 1998 May; 31(6):1414-9. PubMed ID: 9581743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion efficacy and safety of repeated doses of ibutilide in patients with atrial flutter and atrial fibrillation. Study Investigators.
    Abi-Mansour P; Carberry PA; McCowan RJ; Henthorn RW; Dunn GH; Perry KT
    Am Heart J; 1998 Oct; 136(4 Pt 1):632-42. PubMed ID: 9778066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of ibutilide for termination of atrial fibrillation and flutter.
    Ellenbogen KA; Clemo HF; Stambler BS; Wood MA; VanderLugt JT
    Am J Cardiol; 1996 Oct; 78(8A):42-5. PubMed ID: 8903275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
    Nair M; George LK; Koshy SK
    J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
    Vos MA; Golitsyn SR; Stangl K; Ruda MY; Van Wijk LV; Harry JD; Perry KT; Touboul P; Steinbeck G; Wellens HJ
    Heart; 1998 Jun; 79(6):568-75. PubMed ID: 10078083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
    Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
    Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.
    Steinwender C; Hönig S; Kypta A; Kammler J; Schmitt B; Leisch F; Hofmann R
    Int J Cardiol; 2010 Jun; 141(3):260-5. PubMed ID: 19136164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ibutilide with magnesium for conversion of atrial fibrillation or flutter in rheumatic heart disease patients: Ibutilide with magnesium for chemical cardioversion of atrial fibrillation or flutter.
    Malviya A; Kapoor M; Sivam RKN; Khan SA; Pandey R; Kumar U; Ete T; Mishra A
    Indian Heart J; 2020; 72(4):283-288. PubMed ID: 32861384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
    Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
    Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
    Bernard EO; Schmid ER; Schmidlin D; Scharf C; Candinas R; Germann R
    Crit Care Med; 2003 Apr; 31(4):1031-4. PubMed ID: 12682468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
    Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
    Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of ibutilide and propafenone for converting atrial flutter.
    Sun JL; Guo JH; Zhang N; Zhang HC; Zhang P
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):57-64. PubMed ID: 15883757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibutilide for rapid conversion of atrial fibrillation or flutter in a mixed critically ill patient population.
    Delle Karth G; Schillinger M; Geppert A; Haumer M; Gwechenberger M; Meyer B; Heinz G; Siostrzonek P
    Wien Klin Wochenschr; 2005 Feb; 117(3):92-7. PubMed ID: 15773423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ibutilide for cardioversion of recent-onset atrial fibrillation and flutter in elderly.
    Gowda RM; Khan IA; Punukollu G; Mendoza C; Wilbur SL; Vasavada BC; Sacchi TJ
    Am J Ther; 2004; 11(2):95-7. PubMed ID: 14999360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and electrophysiologic effects of calcium channel blockers in patients receiving ibutilide.
    Wood MA; Gilligan DM; Brown-Mahoney C; Nematzadeh F; Stambler BS; Ellenbogen KA
    Am Heart J; 2002 Jan; 143(1):176-80. PubMed ID: 11773930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy.
    Stambler BS; Wood MA; Ellenbogen KA
    Circulation; 1997 Dec; 96(12):4298-306. PubMed ID: 9416896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
    Patsilinakos S; Christou A; Kafkas N; Nikolaou N; Antonatos D; Katsanos S; Spanodimos S; Babalis D
    Am J Cardiol; 2010 Sep; 106(5):673-6. PubMed ID: 20723644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.